NasdaqGM - Delayed Quote USD
Acrivon Therapeutics, Inc. (ACRV)
2.0300
+0.1200
+(6.28%)
At close: 4:00:02 PM EDT
2.0200
-0.01
(-0.49%)
After hours: 6:33:06 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 6.88M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DEVROE ERIC Chief Operating Officer | Conversion of Exercise of derivative security at price 1.04 per share. | Direct | 10,400 | May 17, 2024 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 8.50 per share. | Indirect | 30,005,000 | Apr 11, 2024 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.50 per share. | Indirect | 20,000,500 | Apr 11, 2024 |
| MILLER MARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 26, 2023 |
| BLUME-JENSEN PETER Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 21, 2023 |
| CHIONE, LTD. Beneficial Owner of more than 10% of a Class of Security | Sale at price 12.93 per share. | Indirect | 207 | Jun 26, 2023 |
| HOLM-JORGENSEN RASMUS Chief Financial Officer | Conversion of Exercise of derivative security at price 3.63 per share. | Direct | 34,485 | Jun 16, 2023 |
| CHIONE, LTD. Beneficial Owner of more than 10% of a Class of Security | Sale at price 12.14 per share. | Indirect | 24,960 | Jun 15, 2023 |
| CHIONE, LTD. Beneficial Owner of more than 10% of a Class of Security | Sale at price 12.13 - 12.34 per share. | Indirect | 72,412 | Jun 14, 2023 |
| DEVROE ERIC Chief Operating Officer | Conversion of Exercise of derivative security at price 1.04 per share. | Direct | 9,594 | Jun 5, 2023 |
| BLUME-JENSEN PETER Chief Executive Officer | Conversion of Exercise of derivative security at price 3.88 per share. | Direct | 130,387 | May 31, 2023 |
Related Tickers
LXEO Lexeo Therapeutics, Inc.
3.4200
+6.54%
APM Aptorum Group Limited
0.9130
+9.32%
SPRB Spruce Biosciences, Inc.
0.1296
+7.02%
ARTV Artiva Biotherapeutics, Inc.
2.4500
+2.08%
PEPG PepGen Inc.
1.6200
+6.58%
DTIL Precision BioSciences, Inc.
5.32
+3.70%
PRQR ProQR Therapeutics N.V.
1.3500
+2.27%
SKYE Skye Bioscience, Inc.
1.5100
-3.82%
MTVA MetaVia Inc.
0.7500
+1.35%
KOD Kodiak Sciences Inc.
3.6400
+12.00%